Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients

NCT00745914 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Endstage Renal Disease
Diabetes

Interventions

DRUG: Pioglitazone
DRUG: Placebo comparator

Sponsor

The University of Hong Kong